Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Welcomes New Patient Advisors

Five New Members Added to Advisory Council to Improve Lives of People Living With Parkinson’s

New York, NY, and Miami, FL — The Parkinson’s Foundation is pleased to welcome five new members to its People with Parkinson’s Advisory Council.  The appointments reflect the foundation’s ongoing commitment to engage with the community in its work to create a world without Parkinson’s disease.

“The Parkinson’s Foundation has a track record of listening and responding to the needs of the Parkinson’s community,” said John L. Lehr, chief executive officer, Parkinson’s Foundation.  “We look forward to partnering with our advisors to improve our programs and to ensure that people with Parkinson’s live their best lives today.”

The People with Parkinson’s Advisory Council, established in 2006, is the first patient advisory council in the Parkinson’s space.  Its members have guided the foundation’s work and driven improvements in research, care and patient support.  For example, members have shed light on unmet needs, including underrecognized symptoms such as fatigue and constipation, and have prompted new programs, such as the Women and PD Initiative and the Community Choice Research Awards.

“As people who live with Parkinson’s, our members represent a community of 10 million people worldwide.  We commit ourselves to working on their behalf every single day,” said Daniel Novak, Ph.D., of Fort Worth, TX, chair of the advisory council.  “We applaud the Parkinson’s Foundation for continuing to collaborate with people with Parkinson’s and care partners.  We are stronger together.”

The advisory council’s newest members, elected for a term of three years, represent a wide range of communities, professions and volunteer experiences.  They include the following individuals:

Caryn Balaban, M.P.H., of Phoenix, AZ: a retired healthcare marketing executive, who is care partner to her husband who lives with Parkinson’s.

Daniel DeWitt, Psy.D., of Grand Rapids, MI: a licensed psychologist who has expertise caring for individuals with chronic illnesses.

David Malarkey, D.V.M., Ph.D., of Cary, NC: a veterinary pathologist and research scientist whose scientific career spans 25 years and 100 published papers.

Dana Seyfried, M.A., of Roslyn, NY: a professional who works in animal welfare and a former marketing manager, who is care partner to her father who lives with Parkinson’s.

Robert “Kelly” Sweeney, of Portland, OR: a retired business development and program manager, whose career in the technology industry spanned nearly 40 years.

To learn more and see our full list of advisors, visit www.parkinson.org/ppac.

About Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects nearly one million people in the US and over 10 million worldwide.  Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s and is the 14th leading cause of death in the US. It is associated with a loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety).  Although promising research is being conducted, there is currently no cure for Parkinson’s disease.

About the Parkinson’s Foundation
The Parkinson’s Foundation is working toward a world without Parkinson’s disease.  Formed by the merger of the National Parkinson Foundation and the Parkinson’s Disease Foundation, the mission of the Parkinson’s Foundation is to invest in promising scientific research that will end Parkinson’s disease and improve the lives of people with Parkinson’s, and their families, through improved treatments, support and the best care.  For more information, visit www.parkinsonsfoundation.org or call (800) 4PD-INFO (473-4636) or (800) 457-6676.

Wednesday, May 24, 2017
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.